<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">influenza </span>
   <span class="font18">patients </span>
   <span class="font16">treatment </span>
   <span class="font14">[]. </span>
   <span class="font14">ill </span>
   <span class="font14">virus </span>
   <span class="font13">critically </span>
   <span class="font13">respiratory </span>
   <span class="font13">oseltamivir </span>
   <span class="font13">hospitalized </span>
   <span class="font13">severe </span>
   <span class="font13">clinical </span>
   <span class="font12">risk </span>
   <span class="font12">Infect </span>
   <span class="font12">mortality </span>
   <span class="font11">antiviral </span>
   <span class="font11">infection </span>
   <span class="font11">testing </span>
   <span class="font11">Influenza </span>
   <span class="font11">including </span>
   <span class="font11">reported </span>
   <span class="font11">adults </span>
   <span class="font11">recommended </span>
   <span class="font11">studies </span>
   <span class="font11">tract </span>
   <span class="font11">ICU </span>
   <span class="font11">study </span>
   <span class="font11">viral </span>
   <span class="font11">pandemic </span>
   <span class="font11">{border-style </span>
   <span class="font11">associated </span>
   <span class="font11">children </span>
   <span class="font11">corticosteroid </span>
   <span class="font11">molecular </span>
   <span class="font11">observational </span>
   <span class="font11">px;} </span>
   <span class="font11">vaccination </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">diagnostic </span>
   <span class="font11">lower </span>
   <span class="font11">specimens </span>
   <span class="font11">aged </span>
   <span class="font11">review </span>
   <span class="font11">seasonal </span>
   <span class="font11">systematic </span>
   <span class="font11">disease </span>
   <span class="font11">illness </span>
   <span class="font11">suspected </span>
   <span class="font11">United </span>
   <span class="font11">benefit </span>
   <span class="font11">care </span>
   <span class="font11">complications </span>
   <span class="font11">influenza, </span>
   <span class="font11">neuraminidase </span>
   <span class="font11">novel </span>
   <span class="font11">results </span>
   <span class="font11">tests </span>
   <span class="font11">therapy </span>
   <span class="font10">Disease </span>
   <span class="font10">compared </span>
   <span class="font10">data </span>
   <span class="font10">influenza: </span>
   <span class="font10">intravenous </span>
   <span class="font10">outcomes </span>
   <span class="font10">randomized </span>
   <span class="font10">reducing </span>
   <span class="font10"> mg </span>
   <span class="font10">admitted </span>
   <span class="font10">baloxavir </span>
   <span class="font10">early </span>
   <span class="font10">peramivir </span>
   <span class="font10">twice </span>
   <span class="font10">upper </span>
   <span class="font10">Care </span>
   <span class="font10">Control </span>
   <span class="font10">available </span>
   <span class="font10">chronic </span>
   <span class="font10">daily </span>
   <span class="font10">dose </span>
   <span class="font10">high </span>
   <span class="font10">increased </span>
   <span class="font10">inhibitors </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">receiving </span>
   <span class="font10">reduction </span>
   <span class="font10">safety </span>
   <span class="font10">trial </span>
   <span class="font10">A(HN) </span>
   <span class="font10">High </span>
   <span class="font10">[], </span>
   <span class="font10">acute </span>
   <span class="font10">assays </span>
   <span class="font10">controlled </span>
   <span class="font10">dosing </span>
   <span class="font10">patients, </span>
   <span class="font10">rapid </span>
   <span class="font10">result </span>
   <span class="font10">uncomplicated </span>
   <span class="font10">viruses </span>
   <span class="font10">(HN) </span>
   <span class="font10">(e.g., </span>
   <span class="font10">NAI </span>
   <span class="font10">Respir </span>
   <span class="font10">U.S. </span>
   <span class="font10">adult </span>
   <span class="font10">combination </span>
   <span class="font10">efficacy </span>
   <span class="font10">factors </span>
   <span class="font10">hospitalization </span>
   <span class="font10">patients. </span>
   <span class="font10">possible </span>
   <span class="font10">px; </span>
   <span class="font10">sensitivity </span>
   <span class="font10">significant </span>
   <span class="font10">underlying </span>
   <span class="font10">vaccine </span>
   <span class="font10">{font-family </span>
   <span class="font10">A(HN)pdm </span>
   <span class="font10">However, </span>
   <span class="font10">[–]. </span>
   <span class="font10">appropriate </span>
   <span class="font10">cases </span>
   <span class="font10">children, </span>
   <span class="font10">collected </span>
   <span class="font10">critical </span>
   <span class="font10">detection </span>
   <span class="font10">duration </span>
   <span class="font10">effectiveness </span>
   <span class="font10">font-size </span>
   <span class="font10">high-risk </span>
   <span class="font10">identified </span>
   <span class="font10">influenza. </span>
   <span class="font10">inhibitor </span>
   <span class="font10">intensive </span>
   <span class="font10">low </span>
   <span class="font10">pediatric </span>
   <span class="font10">persons </span>
   <span class="font10">shedding </span>
   <span class="font10">shown </span>
   <span class="font10">trials </span>
   <span class="font10">use </span>
   <span class="font10">versus </span>
   <span class="font10"> Children </span>
   <span class="font10">Centers </span>
   <span class="font10">Crit </span>
   <span class="font10">Ther./IMP </span>
   <span class="font10">activity </span>
   <span class="font10">adjunctive </span>
   <span class="font10">admission </span>
   <span class="font10">admissions </span>
   <span class="font10">asthma </span>
   <span class="font10">based </span>
   <span class="font10">carboxylate </span>
   <span class="font10">deaths </span>
   <span class="font10">diagnosis </span>
   <span class="font10">double; </span>
   <span class="font10">endotracheal </span>
   <span class="font10">enteric </span>
   <span class="font10">exacerbation </span>
   <span class="font10">extracorporeal </span>
   <span class="font10">failure </span>
   <span class="font10">given </span>
   <span class="font10">health </span>
   <span class="font10">human </span>
   <span class="font10">individual </span>
   <span class="font10">infection. </span>
   <span class="font10">membrane </span>
   <span class="font10">oral </span>
   <span class="font10">pharmacokinetics </span>
   <span class="font10">plasma </span>
   <span class="font10">pneumonia </span>
   <span class="font10">potential </span>
   <span class="font10">preventing </span>
   <span class="font10">prolonged </span>
   <span class="font10">public </span>
   <span class="font10">replication </span>
   <span class="font10">requiring </span>
   <span class="font10">soon </span>
   <span class="font10">– min </span>
   <span class="font10">,–, </span>
   <span class="font10">Accessed </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Apr </span>
   <span class="font10">Available </span>
   <span class="font10">ClinicalTrialsgov </span>
   <span class="font10">Engl </span>
   <span class="font10">Infectious </span>
   <span class="font10">Library </span>
   <span class="font10">Oseltamivir </span>
   <span class="font10">Prevention. </span>
   <span class="font10">agents </span>
   <span class="font10">al.Influenza </span>
   <span class="font10">at: </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cohort </span>
   <span class="font10">conducted </span>
   <span class="font10">currently </span>
   <span class="font10">death </span>
   <span class="font10">estimated </span>
   <span class="font10">hospital </span>
   <span class="font10">infection: </span>
   <span class="font10">influenza-related </span>
   <span class="font10">initiation </span>
   <span class="font10">medical </span>
   <span class="font10">multicenter </span>
   <span class="font10">number </span>
   <span class="font10">onset </span>
   <span class="font10">oxygenation </span>
   <span class="font10">recent </span>
   <span class="font10">reduce </span>
   <span class="font10">reduced </span>
   <span class="font10">septic </span>
   <span class="font10">severity </span>
   <span class="font10">solid; </span>
   <span class="font10">unit </span>
   <span class="font10">variable </span>
   <span class="font10">women </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10"> Adults </span>
   <span class="font10">&amp;gt;  years </span>
   <span class="font10">(Table </span>
   <span class="font10">.Centers </span>
   <span class="font10">Annual </span>
   <span class="font10">Antimicrob </span>
   <span class="font10">BAL </span>
   <span class="font10">Clin </span>
   <span class="font10">Dis./ </span>
   <span class="font10">Dis./cid/cix </span>
   <span class="font10">Immunization </span>
   <span class="font10">Med./NEJMoa </span>
   <span class="font10">Molecular </span>
   <span class="font10">Nasal </span>
   <span class="font10">Rapid </span>
   <span class="font10">States, </span>
   <span class="font10">Table </span>
   <span class="font10">Treatment </span>
   <span class="font10">U.S., </span>
   <span class="font10">[internet]. </span>
   <span class="font10">[–], </span>
   <span class="font10">acid </span>
   <span class="font10">administered </span>
   <span class="font10">administration </span>
   <span class="font10">analysis </span>
   <span class="font10">applicable. </span>
   <span class="font10">assays, </span>
   <span class="font10">bold </span>
   <span class="font10">bronchoalveolar </span>
   <span class="font10">burden </span>
   <span class="font10">conditions </span>
   <span class="font10">considered </span>
   <span class="font10">continue </span>
   <span class="font10">courier; </span>
   <span class="font10">culture </span>
   <span class="font10">did </span>
   <span class="font10">em; </span>
   <span class="font10">evidence </span>
   <span class="font10">higher </span>
   <span class="font10">however, </span>
   <span class="font10">immunocompromised </span>
   <span class="font10">immunomodulatory </span>
   <span class="font10">include </span>
   <span class="font10">infections </span>
   <span class="font10">influenza-associated </span>
   <span class="font10">lavage </span>
   <span class="font10">medications </span>
   <span class="font10">monotherapy </span>
   <span class="font10">negative </span>
   <span class="font10">obese </span>
   <span class="font10">old </span>
   <span class="font10">outcomes. </span>
   <span class="font10">patient </span>
   <span class="font10">performed </span>
   <span class="font10">phase </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">pneumonia, </span>
   <span class="font10">pregnant </span>
   <span class="font10">pt;} </span>
   <span class="font10">randomised </span>
   <span class="font10">recommendations </span>
   <span class="font10">required </span>
   <span class="font10">retrospective </span>
   <span class="font10">season </span>
   <span class="font10">showed </span>
   <span class="font10">similar </span>
   <span class="font10">suggest </span>
   <span class="font10">symptomatic </span>
   <span class="font10">tested </span>
   <span class="font10">throat </span>
   <span class="font10">tract, </span>
   <span class="font10">unless </span>
   <span class="font10">unvaccinated </span>
   <span class="font10">used </span>
   <span class="font10">year </span>
   <span class="font10">young </span>
   <span class="font10"> months </span>
   <span class="font10">≥  years </span>
  </p>
 </body>
</html>
